Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC Trial.
Anup PatelAlain RavaudRobert J MotzerMichael StaehlerBernard EscudierJean-Francois MartiniMariajose LechugaXun LinDaniel J GeorgePublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
In the postnephrectomy high-risk RCC patient cohort, low baseline NLR may help identify those most suitable for adjuvant sunitinib. A ≥25% NLR decrease at week 4 may be an early indicator of those most likely to tolerate treatment and derive DFS benefit.